resveratrol has been researched along with Inflammatory Bowel Diseases in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 6 (35.29) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, S; Sundaram, U; Sundaram, VL; Wellington, VNA | 1 |
| Chaudhary, AA; Gowd, V; Jori, C; Khan, R; Rashid, S; Rudayni, HA | 1 |
| Mao, F; Ocansey, DKW; Pei, B; Wang, N; Wang, Z; Xu, X; Zhang, Y | 1 |
| Chen, Y; Li, C; Pan, Y; Tang, X; Wang, XJ; Zheng, Z | 1 |
| Chen, X; Fang, A; Mao, F; Wang, G; Wang, J; Wu, K; Zhang, Z | 1 |
| Khare, S; Khare, T; Palakurthi, S; Palakurthi, SS; Shah, BM | 1 |
| Abnous, K; Alibolandi, M; Hosseinzadeh, H; Mohammadi, M; Naserifar, M; Ramezani, M; Taghdisi, SM | 1 |
| Jiang, B; Miao, M; Shi, Y; Zhou, J | 1 |
| Danesi, F; Del Rio, D; Nunes, S; Silva, P | 1 |
| Chen, D; He, J; Hu, Y; Mao, X; Yu, B; Yu, J; Zheng, P | 1 |
| Abdollahi, M; Saeidnia, S | 1 |
| Algieri, F; Cenis, JL; de la Fuente, JM; De Matteis, L; Gálvez, J; Garrido-Mesa, J; Garrido-Mesa, N; Lozano-Pérez, AA; Ortiz-Cullera, V; Rodriguez-Cabezas, ME; Rodriguez-Nogales, A; Utrilla, MP; Zorrilla, P | 1 |
| Abdollahi, M; Farzaei, MH; Rahimi, R | 1 |
| Ulutas, PA; Ural, M; Yaylali, A; Yildiz, G; Yildiz, Y | 1 |
| Kundu, JK; Lee, JS; Na, HK; Surh, YJ; Youn, J | 1 |
| Busbee, B; Guan, H; Mishra, MK; Nagarkatti, M; Nagarkatti, PS; Price, RL; Singh, B; Singh, NP; Singh, UP; Taub, DD | 1 |
| Acquafredda, A; Carofiglio, V; Cavallo, P; Cianciulli, A; Panaro, MA | 1 |
9 review(s) available for resveratrol and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Dietary Supplementation with Vitamin D, Fish Oil or Resveratrol Modulates the Gut Microbiome in Inflammatory Bowel Disease.
Topics: Animals; Dietary Supplements; Fish Oils; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Resveratrol; Vitamin D | 2021 |
Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Delayed-Action Preparations; Humans; Inflammatory Bowel Diseases; MicroRNAs; Nanoparticle Drug Delivery System; NF-kappa B; Polyphenols; Resveratrol; Sirtuin 1; Synthetic Drugs; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha; Water | 2022 |
Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease.
Topics: Animals; Benzoquinones; Biological Products; Biomimetics; Caffeic Acids; Curcumin; Cytokines; Exosomes; Humans; Inflammation; Inflammatory Bowel Diseases; Insecta; Macromolecular Substances; Nanomedicine; Oxidative Stress; Phenylethyl Alcohol; Phytochemicals; Plant Extracts; Polysaccharides; Quercetin; Resveratrol; Stilbenes; Transcription Factors; Translational Research, Biomedical; Vasoactive Intestinal Peptide; Zingiber officinale | 2020 |
Resveratrol and inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Antioxidants; Humans; Inflammatory Bowel Diseases; Resveratrol; Stilbenes; Treatment Outcome | 2017 |
Resveratrol and inflammatory bowel disease: the evidence so far.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Diet; Humans; Inflammation; Inflammatory Bowel Diseases; Intestinal Absorption; Intestinal Mucosa; Phytotherapy; Plant Extracts; Polyphenols; Resveratrol | 2018 |
The Bidirectional Interactions between Resveratrol and Gut Microbiota: An Insight into Oxidative Stress and Inflammatory Bowel Disease Therapy.
Topics: Biological Availability; Dysbiosis; Enterobacteriaceae; Gastrointestinal Microbiome; Homeostasis; Humans; Inflammatory Bowel Diseases; Intestines; Lactococcus lactis; Oxidative Stress; Polyphenols; Reactive Oxygen Species; Resveratrol | 2019 |
Toxicological and pharmacological concerns on oxidative stress and related diseases.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzopyrans; Carbazoles; Carvedilol; Diabetes Mellitus; Disease Models, Animal; Ethanolamines; Humans; Hydrogen Peroxide; Inflammatory Bowel Diseases; Nebivolol; Neoplasms; Neurodegenerative Diseases; Osteoporosis; Oxidative Stress; Propanolamines; Reactive Oxygen Species; Resveratrol; Stilbenes; Vascular Diseases | 2013 |
The role of dietary polyphenols in the management of inflammatory bowel disease.
Topics: Animals; Curcumin; Disease Management; Fruit; Humans; Inflammatory Bowel Diseases; Oxidative Stress; Plant Extracts; Polyphenols; Resveratrol; Stilbenes; Tea | 2015 |
Alternative medicines as emerging therapies for inflammatory bowel diseases.
Topics: Adrenal Cortex Hormones; Animals; Clinical Trials as Topic; Complementary Therapies; Humans; Inflammatory Bowel Diseases; Phytotherapy; Plants; Resveratrol; Rutin; Stilbenes | 2012 |
8 other study(ies) available for resveratrol and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis.
Topics: Animals; Arginine; Gastrointestinal Microbiome; Inflammatory Bowel Diseases; Macrophages; Mice; Resveratrol | 2023 |
Synthetic Imine Resveratrol Analog 2-Methoxyl-3,6-Dihydroxyl-IRA Ameliorates Colitis by Activating Protective Nrf2 Pathway and Inhibiting NLRP3 Expression.
Topics: Animals; Cell Line; Colitis; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Humans; Imines; Inflammatory Bowel Diseases; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol; Signal Transduction | 2019 |
Resveratrol Attenuates Inflammatory Bowel Disease in Mice by Regulating SUMO1.
Topics: Animals; Anti-Inflammatory Agents; beta Catenin; Cell Culture Techniques; Colitis; Colon; Colorectal Neoplasms; Cytokines; Dextran Sulfate; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Resveratrol; Spleen; SUMO-1 Protein; Wnt Signaling Pathway | 2020 |
Oral delivery of folate-targeted resveratrol-loaded nanoparticles for inflammatory bowel disease therapy in rats.
Topics: Administration, Oral; Animals; Caco-2 Cells; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Folic Acid; Humans; Inflammatory Bowel Diseases; Male; Nanoparticles; Permeability; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Resveratrol | 2020 |
Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Cell Line; Colon; Cytokines; Delayed-Action Preparations; Disease Models, Animal; Inflammatory Bowel Diseases; Nanoparticles; Particle Size; Rats; Resveratrol; Silk; Stilbenes | 2014 |
Resveratrol Pretreatment Ameliorates TNBS Colitis in Rats.
Topics: Animals; Antioxidants; Colitis; Female; Inflammatory Bowel Diseases; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Trinitrobenzenesulfonic Acid | 2015 |
Resveratrol and piceatannol inhibit iNOS expression and NF-kappaB activation in dextran sulfate sodium-induced mouse colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colonic Neoplasms; Dextran Sulfate; DNA-Binding Proteins; Down-Regulation; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; I-kappa B Kinase; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Resveratrol; STAT3 Transcription Factor; Stilbenes; Time Factors | 2009 |
Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Dietary Supplements; Down-Regulation; Enterocytes; Humans; I-kappa B Proteins; Inflammatory Bowel Diseases; Lipopolysaccharides; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Protein Processing, Post-Translational; Proteolysis; Resveratrol; RNA, Messenger; Stilbenes; Toll-Like Receptor 4 | 2012 |